ZTS · 8-K · 20260806PR338080

Management Changes

Zoetis Inc. · 2026-08-06 · Importance 31 · Surprise 42

Zoetis appointed James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. In the newly created role, Saccaro will lead global finance, including capital allocation, financial strategy, reporting and controls, and investor engagement. He will also oversee Global Manufacturing and Supply to drive operational execution and performance. Wetteny Joseph will transition to an advisory role on August 17, 2026 and remain as Special Advisor to the CEO on financial matters until early 2027 to facilitate the transition.

Key facts

• Zoetis announced the appointment of James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer. source
• James (Jay) Saccaro's appointment is effective August 17, 2026. source
• In the newly created role, Mr. Saccaro will lead Zoetis’ global finance function and oversee Global Manufacturing and Supply. source
• Mr. Saccaro served as Vice President and Chief Financial Officer at GE HealthCare since 2023. source
• Mr. Saccaro spent over two decades at Baxter International Inc. source
• Mr. Saccaro served as Executive Vice President and CFO at Baxter International Inc. from 2015 to 2023. source
• Mr. Saccaro held the role of Executive Vice President and Chief Financial Officer at Baxter for eight years. source
• Mr. Saccaro led business development for Baxter’s $5 billion Medication Delivery unit. source